Literature DB >> 33002918

Nonkeratinizing Squamous Cell Carcinoma of the Sinonasal Tract With DEK-AFF2: Further Solidifying an Emerging Entity.

Justin A Bishop1, Jeffrey Gagan1, Claire Paterson2, Douglas McLellan3, Ann Sandison4.   

Abstract

Entities:  

Year:  2021        PMID： 33002918     DOI： 10.1097/PAS.0000000000001596

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN： 0147-5185            Impact factor:   6.394


× No keyword cloud information.
  6 in total

1.  First Report of Thoracic Carcinoma With DEK::AFF2 Rearrangement: A Case Report.

Authors:  Omid Savari; Jason C Chang; Justin A Bishop; Muthu Kumar Sakthivel; Frederic B Askin; Natasha Rekhtman
Journal:  J Thorac Oncol       Date:  2022-06-28       Impact factor: 20.121

2.  Unclassified Neuroendocrine Tumor with a Novel CHD4::AFF2 Fusion: Expanding the Family of AFF2-Rearranged Head and Neck Malignancies.

Authors:  Daniel L Miller; Doreen N Palsgrove; Anu Rijal; Vivan Hathuc; Rebecca Chernock; Jeffrey Gagan; Justin A Bishop
Journal:  Head Neck Pathol       Date:  2022-02-26

Review 3.  Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Nasal Cavity, Paranasal Sinuses and Skull Base.

Authors:  Lester D R Thompson; Justin A Bishop
Journal:  Head Neck Pathol       Date:  2022-03-21

4.  Pyroptosis-Related Signature and Tumor Microenvironment Infiltration Characterization in Head and Neck Squamous Cell Carcinoma.

Authors:  Zeng-Hong Wu; Bian Wu; Cheng Li; You-Jing Zhang; Tao Zhou
Journal:  Front Cell Dev Biol       Date:  2022-05-31

5.  Low Grade Papillary Sinonasal (Schneiderian) Carcinoma: A Series of Five Cases of a Unique Malignant Neoplasm with Comparison to Inverted Papilloma and Conventional Nonkeratinizing Squamous Cell Carcinoma.

Authors:  Mario W Saab-Chalhoub; Xingyi Guo; Qiuying Shi; Rebecca D Chernock; James S Lewis
Journal:  Head Neck Pathol       Date:  2021-05-26

Review 6.  Towards a Molecular Classification of Sinonasal Carcinomas: Clinical Implications and Opportunities.

Authors:  Cecilia Taverna; Abbas Agaimy; Alessandro Franchi
Journal:  Cancers (Basel)       Date:  2022-03-12       Impact factor: 6.639
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.